Benign and Malignant Prostatic Neoplasms: Human Studies
1994; Elsevier BV; Linguagem: Inglês
10.1016/b978-0-12-571149-4.50020-9
AutoresAlan W. Partin, Donald S. Coffey,
Tópico(s)Urologic and reproductive health conditions
ResumoThis chapter discusses benign and malignant prostatic neoplasms. The two most prevalent and clinically important forms of abnormal prostatic growth are benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma. Surgery for BPH in the form of a transurethral resection is the most often used modality for treatment and is performed over 4,00,000 times each year in the United States. This makes BPH the second leading cause of surgery in the male, second only to cataract surgery. The symptom complex caused by BPH—often termed prostatism—can be divided into two main categories: (1) obstructive symptoms and (2) irritative symptoms. Obstructive urinary symptoms consist of a weak stream, abdominal straining, hesitancy, intermittency, incomplete bladder emptying, and terminal dribbling. Irritative symptoms include frequency, nocturia, and urgency. Patients presenting with BPH have symptoms that vary over a broad range. Standardized symptom scores and efforts to organize the indications for therapy, coupled with good clinical judgment and the patients' bother factor, dictate the need for treatment for this disease.
Referência(s)